282
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis

, , , , , , , , , , & show all
Pages 430-438 | Received 18 Feb 2011, Accepted 21 Apr 2011, Published online: 24 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

. (2014) THEME 1 IMPROVING DIAGNOSIS, PROGNOSIS AND DISEASE PROGRESSION. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:sup1, pages 57-67.
Read now

Articles from other publishers (19)

Stefan Mimic, Başak Aru, Cemil Pehlivanoğlu, Hadi Sleiman, Pavle R. Andjus & Gülderen Yanıkkaya Demirel. (2023) Immunology of amyotrophic lateral sclerosis – role of the innate and adaptive immunity. Frontiers in Neuroscience 17.
Crossref
Hélèna L. Denis, Melanie Alpaugh, Claudia P. Alvarez, Alexis Fenyi, Roger A. Barker, Sylvain Chouinard, Cheryl H. Arrowsmith, Ronald Melki, Richard Labib, Rachel J. Harding & Francesca Cicchetti. (2023) Detection of antibodies against the huntingtin protein in human plasma. Cellular and Molecular Life Sciences 80:2.
Crossref
Meenakshi Sundaram Kumar, Megan E. Fowler-Magaw, Daniel Kulick, Sivakumar Boopathy, Del Hayden Gadd, Melissa Rotunno, Catherine Douthwright, Diane Golebiowski, Issa Yusuf, Zuoshang Xu, Robert H. BrownJr.Jr., Miguel Sena-Esteves, Alison L. O'Neil & Daryl A. Bosco. (2022) Anti-SOD1 Nanobodies That Stabilize Misfolded SOD1 Proteins Also Promote Neurite Outgrowth in Mutant SOD1 Human Neurons. International Journal of Molecular Sciences 23:24, pages 16013.
Crossref
Giuseppe Schirò, Vincenzo Di Stefano, Salvatore Iacono, Antonino Lupica, Filippo Brighina, Roberto Monastero & Carmela Rita Balistreri. (2022) Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis. Brain Sciences 12:10, pages 1412.
Crossref
Yoshiaki Furukawa & Eiichi Tokuda. (2020) Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?. Translational Neurodegeneration 9:1.
Crossref
Eiichi Tokuda, Yo-ichi Takei, Shinji Ohara, Noriko Fujiwara, Isao Hozumi & Yoshiaki Furukawa. (2019) Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis. Molecular Neurodegeneration 14:1.
Crossref
Sid E. O'Bryant, Melissa Edwards, Fan Zhang, Leigh A. Johnson, James Hall, Yuliya Kuras & Clemens R. Scherzer. (2019) Potential two‐step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11:1, pages 374-382.
Crossref
Gareth S. A. Wright, Svetlana V. Antonyuk & S. Samar Hasnain. (2019) The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis. Quarterly Reviews of Biophysics 52.
Crossref
Marcel Maier, Tobias Welt, Fabian WirthFabio Montrasio, Daniel PreisigJordan McAfooseFernando G. Vieira, Luka Kulic, Claudia Späni, Thilo StehleSteve PerrinMarkus WeberChristoph HockRoger M. NitschJan Grimm. (2018) A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Science Translational Medicine 10:470.
Crossref
W. Allison, Michèle DuVal, Kim Nguyen-Phuoc & Patricia Leighton. (2017) Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology. International Journal of Molecular Sciences 18:10, pages 2223.
Crossref
Charles Schutt, Howard E. Gendelman & R. Lee Mosley. 2017. Neuroimmune Pharmacology. Neuroimmune Pharmacology 767 797 .
Owen M. Peters, Mehdi Ghasemi & Robert H. BrownJr.Jr.. (2015) Emerging mechanisms of molecular pathology in ALS. Journal of Clinical Investigation 125:5, pages 1767-1779.
Crossref
Andrea Malaspina, Fabiola Puentes & Sandra Amor. (2015) Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. International Immunology 27:3, pages 117-129.
Crossref
Monica Bucchia, Agnese Ramirez, Valeria Parente, Chiara Simone, Monica Nizzardo, Francesca Magri, Sara Dametti & Stefania Corti. (2015) Therapeutic Development in Amyotrophic Lateral Sclerosis. Clinical Therapeutics 37:3, pages 668-680.
Crossref
F. Puentes, J. Topping, J. Kuhle, B. J. van der Star, A. Douiri, G. Giovannoni, D. Baker, S. Amor & A. Malaspina. (2013) Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 85:3, pages 274-278.
Crossref
Kevin D Foust, Desirée L Salazar, Shibi Likhite, Laura Ferraiuolo, Dara Ditsworth, Hristelina Ilieva, Kathrin Meyer, Leah Schmelzer, Lyndsey Braun, Don W Cleveland & Brian K Kaspar. (2013) Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS. Molecular Therapy 21:12, pages 2148-2159.
Crossref
Inhee Choi, Elizabeth Lee & Luke P. Lee. (2014) Current nano/biotechnological approaches in amyotrophic lateral sclerosis. Biomedical Engineering Letters 3:4, pages 209-222.
Crossref
Teresa J. Broering, Hongyan Wang, Naomi K. Boatright, Yang Wang, Katherine Baptista, Gilda Shayan, Kerry A. Garrity, Can Kayatekin, Daryl A. Bosco, C. Robert Matthews, Donna M. Ambrosino, Zuoshang Xu & Gregory J. Babcock. (2013) Identification of Human Monoclonal Antibodies Specific for Human SOD1 Recognizing Distinct Epitopes and Forms of SOD1. PLoS ONE 8:4, pages e61210.
Crossref
Vikram Khipple Mulligan, Aaron Kerman, Rob C. Laister, Priya Roy Sharda, Pharhad Eli Arslan & Avijit Chakrabartty. (2012) Early Steps in Oxidation-Induced SOD1 Misfolding: Implications for Non-Amyloid Protein Aggregation in Familial ALS. Journal of Molecular Biology 421:4-5, pages 631-652.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.